Related Experiment Video
Updated: May 20, 2026

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Villous papillary thyroid carcinoma: a variant associated with marfan syndrome
Daniel A Winer1, Shawn Winer, Lorne Rotstein
1Department of Pathology, University Health Network, Toronto, ON, Canada.
Abstract:
Marfan syndrome (MFS) is an autosomal dominant hereditary disorder of connective tissue associated with perturbations in transforming growth factor β (TGF-β) biology, most often due to mutations in FBN1 gene that encodes fibrillin-1. To our knowledge, there is no known association of MFS with thyroid carcinoma. We report a 46-year-old man with known history of MFS who developed an unusual histological variant of papillary thyroid carcinoma. The tumor exhibited a widely invasive florid papillary growth pattern with prominent long villous fronds. Immunohistochemical and molecular analysis revealed a BRAF(V600E) mutation, evidence of aggressive biomarker expression (positivity for HBME-1, cytokeratin 19, galectin-3 and cyclin D1, and loss of p27), and changes associated with TGF-β-related epithelial-to-mesenchymal transition with active phospho-SMAD signaling. We introduce a unique histological pattern of papillary thyroid carcinoma that is associated with MFS. The combination of BRAF(V600E) mutation in the setting of altered TGF-β signaling and weak connective tissue integrity associated with MFS may cooperate and possibly be responsible to form this unique villous morphology with epithelial-to-mesenchymal transition and invasive growth.
Insights
Marfan syndrome (MFS), a connective tissue disorder, is unusually linked to a distinct papillary thyroid carcinoma variant. This rare association involves specific genetic mutations and aggressive tumor features.
Area of Science:
- Oncology
- Genetics
- Connective Tissue Disorders
Background:
- Marfan syndrome (MFS) is a genetic connective tissue disorder linked to transforming growth factor β (TGF-β) pathway dysregulation, typically caused by FBN1 mutations.
- No prior association between Marfan syndrome and thyroid carcinoma has been documented.
Observation:
- A 46-year-old male with Marfan syndrome developed an uncommon papillary thyroid carcinoma variant.
- The tumor displayed a florid, widely invasive papillary growth pattern with prominent villous fronds.
Findings:
- Immunohistochemical and molecular analyses identified a BRAF(V600E) mutation.
- Aggressive biomarkers (HBME-1, cytokeratin 19, galectin-3, cyclin D1) were positive, with p27 loss.
- Evidence of TGF-β-related epithelial-to-mesenchymal transition (EMT) and active phospho-SMAD signaling was observed.
Implications:
- This case introduces a unique histological pattern of papillary thyroid carcinoma associated with Marfan syndrome.
- The interplay of BRAF(V600E) mutation, altered TGF-β signaling, and compromised connective tissue integrity in MFS may drive this distinct tumor morphology and invasive behavior.
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Aneurysm I: Introduction
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hyperthyroidism II: Pathophysiology

